Animal models for heart valve research and development

Q3 Pharmacology, Toxicology and Pharmaceutics
Arash Kheradvar , Ramin Zareian , Shimako Kawauchi , Richard L. Goodwin , Sandra Rugonyi
{"title":"Animal models for heart valve research and development","authors":"Arash Kheradvar ,&nbsp;Ramin Zareian ,&nbsp;Shimako Kawauchi ,&nbsp;Richard L. Goodwin ,&nbsp;Sandra Rugonyi","doi":"10.1016/j.ddmod.2018.04.001","DOIUrl":null,"url":null,"abstract":"<div><p><span><span><span>Valvular heart disease<span> is the third-most common cause of heart problems in the United States. Malfunction of the valves can be acquired or congenital and each may lead either to stenosis or regurgitation, or even both in some cases. Heart valve disease is a progressive disease, which is irreversible and may be fatal if left untreated. Medications cannot currently prevent valvular calcification or help repair damaged valves, as valve tissue is unable to regenerate spontaneously. Thus, heart valve replacement/repair is the only current available treatment. Heart valve research and development is currently focused on two parallel paths; first, research that aims to understand the underlying mechanisms for heart valve disease to emerge with an ultimate goal to devise medical treatment; and second, efforts to develop repair and replacement options for a diseased valve. Studies that focus on developmental malformation, including </span></span>genetic<span> and epigenetic causes, usually employ small </span></span>animal models that are easy to access for </span><em>in vivo</em> imaging that minimally disturbs their environment during early stages of development. Alternatively, studies that aim to develop novel devices for replacement and repair of diseased valves often employ large animals whose heart size and anatomy closely replicate human’s. This paper aims to briefly review the current state-of-the-art animal models, and justification to use an animal model for a particular heart valve related project.</p></div>","PeriodicalId":39774,"journal":{"name":"Drug Discovery Today: Disease Models","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ddmod.2018.04.001","citationCount":"17","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Discovery Today: Disease Models","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1740675717300488","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 17

Abstract

Valvular heart disease is the third-most common cause of heart problems in the United States. Malfunction of the valves can be acquired or congenital and each may lead either to stenosis or regurgitation, or even both in some cases. Heart valve disease is a progressive disease, which is irreversible and may be fatal if left untreated. Medications cannot currently prevent valvular calcification or help repair damaged valves, as valve tissue is unable to regenerate spontaneously. Thus, heart valve replacement/repair is the only current available treatment. Heart valve research and development is currently focused on two parallel paths; first, research that aims to understand the underlying mechanisms for heart valve disease to emerge with an ultimate goal to devise medical treatment; and second, efforts to develop repair and replacement options for a diseased valve. Studies that focus on developmental malformation, including genetic and epigenetic causes, usually employ small animal models that are easy to access for in vivo imaging that minimally disturbs their environment during early stages of development. Alternatively, studies that aim to develop novel devices for replacement and repair of diseased valves often employ large animals whose heart size and anatomy closely replicate human’s. This paper aims to briefly review the current state-of-the-art animal models, and justification to use an animal model for a particular heart valve related project.

Abstract Image

Abstract Image

心脏瓣膜动物模型的研究与开发
在美国,瓣膜性心脏病是导致心脏问题的第三大常见原因。瓣膜的功能障碍可以是后天的,也可以是先天性的,每一种都可能导致狭窄或反流,甚至在某些情况下两者兼而有之。心脏瓣膜疾病是一种进行性疾病,是不可逆转的,如果不及时治疗可能会致命。药物目前还不能预防瓣膜钙化或帮助修复受损的瓣膜,因为瓣膜组织不能自发再生。因此,心脏瓣膜置换/修复是目前唯一可行的治疗方法。心脏瓣膜的研究和开发目前主要集中在两条平行的路径上;首先,研究旨在了解心脏瓣膜疾病的潜在机制,最终目标是设计医疗方案;第二,努力开发修复和更换病变瓣膜的选择。关注发育畸形的研究,包括遗传和表观遗传原因,通常采用小动物模型,这些模型易于获得体内成像,在发育早期对其环境的干扰最小。另外,旨在开发用于替换和修复病变瓣膜的新设备的研究通常使用大型动物,这些动物的心脏大小和解剖结构与人类非常相似。本文旨在简要回顾目前最先进的动物模型,以及在特定心脏瓣膜相关项目中使用动物模型的理由。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug Discovery Today: Disease Models
Drug Discovery Today: Disease Models Pharmacology, Toxicology and Pharmaceutics-Drug Discovery
自引率
0.00%
发文量
0
期刊介绍: Drug Discovery Today: Disease Models discusses the non-human experimental models through which inference is drawn regarding the molecular aetiology and pathogenesis of human disease. It provides critical analysis and evaluation of which models can genuinely inform the research community about the direct process of human disease, those which may have value in basic toxicology, and those which are simply designed for effective expression and raw characterisation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信